Morgan Stanley upgrades Arrowhead Pharma stock rating on drug trial outlook

Investing_ng | 21-04-2026 09:24pm |

Morgan Stanley upgrades Arrowhead Pharma stock rating on drug trial outlook

Related Articles

NNPC contributes the most monthly tax re... Business
I Receive Threat Calls Over My Reforms I... Top
Portable Injured, Other Artistes Missing... Entertainment
Tinubu Leaves For France Today Top
Vietnam-bound bizman excretes 88 cocaine... Health
Nigerian Govt Moves To Introduce New Tax... Top

Stay Updated with the Latest News!

Don't miss out on breaking stories and in-depth articles.

See the latest News